TY - JOUR
T1 - Relationships of hypoglycemia awareness, hypoglycemia beliefs, and continuous glucose monitoring glycemic profiles with anxiety and depression symptoms in adults with type 1 diabetes using continuous glucose monitoring systems
AU - Lin, Yu Kuei
AU - Hepworth, Emily
AU - de Zoysa, Nicole
AU - McCurley, Jessica
AU - Vajravelu, Mary Ellen
AU - Ye, Wen
AU - Piatt, Gretchen A.
AU - Amiel, Stephanie A.
AU - Fisher, Simon J.
AU - Pop-Busui, Rodica
AU - Aikens, James E.
N1 - Publisher Copyright:
© 2024 Elsevier B.V.
PY - 2024/3
Y1 - 2024/3
N2 - Aims: To evaluate relationships of hypoglycemia awareness, hypoglycemia beliefs, and continuous glucose monitoring (CGM) glycemic profiles with anxiety and depression symptoms in adults with type 1 diabetes (T1D) who use CGM. Methods: A cross-sectional survey and data collections were completed with 196 T1D adults who used CGM (59% also used automated insulin delivery devices (AIDs)). We assessed hypoglycemia awareness (Gold instrument), hypoglycemia beliefs (Attitudes to Awareness of Hypoglycemia instrument), CGM glycemic profiles, demographics, and anxiety and depression symptoms (Hospital Anxiety and Depression Scale). Analysis included simple and multiple linear regression analyses. Results: Lower hypoglycemia awareness, weaker “hypoglycemia concerns minimized” beliefs, stronger “hyperglycemia avoidance prioritized” beliefs were independently associated with higher anxiety symptoms (P < 0.05), with similar trends in both subgroups using and not using AIDs. Lower hypoglycemia awareness were independently associated with greater depression symptoms (P < 0.05). In participants not using AIDs, more time in hypoglycemia was related to less anxiety and depression symptoms (P < 0.05). Being female and younger were independently associated with higher anxiety symptoms, while being younger was also independently associated with greater depression symptoms (P < 0.05). Conclusion: Our findings revealed relationships of impaired hypoglycemia awareness, hypoglycemia beliefs, CGM-detected hypoglycemia with anxiety and depression symptoms in T1D adults who use CGMs.
AB - Aims: To evaluate relationships of hypoglycemia awareness, hypoglycemia beliefs, and continuous glucose monitoring (CGM) glycemic profiles with anxiety and depression symptoms in adults with type 1 diabetes (T1D) who use CGM. Methods: A cross-sectional survey and data collections were completed with 196 T1D adults who used CGM (59% also used automated insulin delivery devices (AIDs)). We assessed hypoglycemia awareness (Gold instrument), hypoglycemia beliefs (Attitudes to Awareness of Hypoglycemia instrument), CGM glycemic profiles, demographics, and anxiety and depression symptoms (Hospital Anxiety and Depression Scale). Analysis included simple and multiple linear regression analyses. Results: Lower hypoglycemia awareness, weaker “hypoglycemia concerns minimized” beliefs, stronger “hyperglycemia avoidance prioritized” beliefs were independently associated with higher anxiety symptoms (P < 0.05), with similar trends in both subgroups using and not using AIDs. Lower hypoglycemia awareness were independently associated with greater depression symptoms (P < 0.05). In participants not using AIDs, more time in hypoglycemia was related to less anxiety and depression symptoms (P < 0.05). Being female and younger were independently associated with higher anxiety symptoms, while being younger was also independently associated with greater depression symptoms (P < 0.05). Conclusion: Our findings revealed relationships of impaired hypoglycemia awareness, hypoglycemia beliefs, CGM-detected hypoglycemia with anxiety and depression symptoms in T1D adults who use CGMs.
KW - Anxiety
KW - Continuous glucose monitoring
KW - Depression
KW - Hypoglycemia
KW - Type 1 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85186750342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85186750342&partnerID=8YFLogxK
U2 - 10.1016/j.diabres.2024.111596
DO - 10.1016/j.diabres.2024.111596
M3 - Article
C2 - 38428746
AN - SCOPUS:85186750342
SN - 0168-8227
VL - 209
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
M1 - 111596
ER -